1/21/2021Lesson from China's National Negotiation of Drug Prices in 2020

1/19/2021PL: Facing Aggressive Price Cuts at Home, Chinese Biotechs Must Go Glo...

1/19/2021BioWorld: Luye's Schizophrenia Drug Approval in China Challenges J&J's...

1/19/2021Innovent Announces an Out-license Deal with PT Etana to Launch Bevaciz...

1/19/2021TenNor Enters Research Collaboration with Janssen for Potential New Tr...

1/19/2021Everest Medicines Announces Amended Agreement with Spero Therapeutics

1/19/2021NMPA Announces OTC Switch of Budesonide Nasal Spray

1/19/2021NMPA Revises Packages Inserts of Pamidronate Disodium Injection

1/19/2021TRACON Granted Priority Review Acceptance of Envafolimab NDA in Chin...

1/19/2021Yidu CEO: A New Chinese Healthcare Billionaires Is Born

1/18/2021Kyowa Kirin Granted Conditional Approval of Crysvita (burosumab) in Ch...

1/18/2021CDE Issues the Technical Guidelines for Clinical Trial of Innovative N...

1/18/2021Teva Launches Huntington's Drug Austedo in China

1/18/2021USTR Unleashes 2020 Report for China's WTO Compliance Highlighting IP ...

1/18/2021Top JPMorgan Banker Sees Steady Supply of Chinese Health Care IPOs, Ev...

1/15/2021CDE Issues the Technical Guidelines for Quality Studies of TCM New Dru...

1/15/2021Innovent's sNDA for Sintilimab as Second-line Therapy for Squamous NSC...

1/15/2021CDE Issues the Technical Guidelines for Image Evaluation Procedures an...

1/15/2021JPO Issues Bidding Documents for the Fourth Batch of VBP

1/15/2021Recent Executive Moves

1/14/2021NHSA Highlights Ten Major Tasks in 2021

1/14/2021Chiome and Henlius Sign Greater China Licensing Deal for Anti-TPOR-2 A...

1/14/2021EOC Pharma Licenses Aadi Bioscience's mTOR Inhibitor in Greater China

1/14/2021China Officially Bans Phenolphthalein Tablets and Lozenges Due to Seri...

1/14/2021Reform Has Unleashed Chinese Drugs Innovation Boom, Though Some Pharma...

1/14/2021What Do Novartis Deal, PD-1 Competition In China Mean For Tislelizumab...

1/14/2021Pharma Companies to Cut Prices of News Drugs by 51% to Access Chinese ...

1/14/2021Novartis, Once Wary of Chinese M&A, Dives into BeiGene's Cancer Immuno...

1/13/2021NMPA Issues the Measures for Post Marketing Changes of Drug Products

1/13/2021Domestic PD-1s in the 2020 NRDL Negotiated Entry: Winners Take All

Page:218/789 Total number of articles:23668: [First][<<] [216] [217] [218] [219] [220] [>>] [End]